KPMG Healthcare & Life Sciences Institute

Ed Giniat

‹

›

Ed Giniat

Partner, National Sector Leader, Healthcare, KPMG (US)

+1 312-665-2073

Email Me

Explore KPMG insights

Featured thought leadership

Promoting interoperability

CMS and ONC proposed rules on the exchange of health information

More
Embracing transparency

Instead of viewing calls for transparency as a burden, pharmaceutical companies can take steps to turn pricing reform to their advantage.

More
Opportunities in an evolving market

2019 Health Care & Life Sciences Investment Outlook

More
Driving value from genomics in Life Sciences

Rising to the data challenge

More
On the 2019 healthcare board agenda

Board and audit committee agendas should continue to evolve in 2019 amid the game-changing implications of technology, consolidation, and new entrants.

More
R&D 2030

Reinvent innovation and become an R&D front-runner by 2030

More
The evolution of government programs in the U.S.

Balancing opportunity and risk to bring your drug to this important market.

More
Navigating the U.S. government market

Top 5 factors every biotech and pharmaceutical company should keep in mind

More
Digital transformation in regulatory affairs

Unlocking value for life sciences organizations

More
Pharmaceuticals industry exec summary - Harvey Nash/KPMG CIO survey 2018

This CIO Survey is the largest IT leadership study in the world, and summarizes what we learned about the transformational CIO.

More
The race to EU MDR compliance

KPMG/RAPS survey illustrates the ground medical device companies still have to cover

More
Harvey Nash / KPMG CIO Survey 2018

Results indicate that the CIO role is transforming as organizations strive to be customer-centric in an environment of increased risk and aim to make a success of digital.

More
Data governance

Driving value in healthcare

More
Future of finance in healthcare

Finance disrupted - As the industry adjusts to continuous disruption, the finance function has an opportunity to lead

More
Digital health and disruption in diabetes

Identifying opportunities for life sciences manufacturers.

More
Insider threat in life sciences

2018 Program benchmark report

More
Promoting interoperability

CMS and ONC proposed rules on the exchange of health information

More

KPMG Healthcare & Life Sciences Institute

Register to receive timely insights